- Hem
- Böcker
- Kurslitteratur
- Vård, Omsorg & Medicin
- Drug Development (inbunden, eng)
Drug Development (inbunden, eng)
The application of molecular techniques to gastroenterology continues to yield important advances in the development of drugs to treat gastr...
239 kr
269 kr
Slut i lager
Fri frakt över 299:-
Snabb leverans
Alltid låga priser
Produktbeskrivning
The application of molecular techniques to gastroenterology continues to yield important advances in the development of drugs to treat gastrointestinal disorders. Important new drugs have emerged through the collaborative and complementary efforts of basic scientists, clinicians, and clinical researchers in academia and the pharmaceutical industry.
The challenge has been exciting, with a few surprises along the way. Consider peptic ulcer disease as an example. The discovery of H receptors and the availability of potent and 2 selective H-receptor antagonists signaled the beginning of a new era 2 in the treatment of gastric hypersecretory states and peptic ulcers.
Introduction of proton pump inhibitors offered another therapeutic option. Though H-receptor antagonists and proton pump inhibitors 2 are important and useful drugs, the discovery of the link between H. pylori infection and peptic ulcer disease has led to even more effective pharmacotherapeutic regimens.
Our intent in Drug Development: Molecular Targets for GI Diseases is to bring together hands-on experts to review promising areas of gastrointestinal pharmacology. The contemporary topics covered, from a mechanistic viewpoint, are relevant to gastrointestinal inflammation and motility disorders.
Authoritative opinions are offered on both future research directions and potential applications for new therapies.
The challenge has been exciting, with a few surprises along the way. Consider peptic ulcer disease as an example. The discovery of H receptors and the availability of potent and 2 selective H-receptor antagonists signaled the beginning of a new era 2 in the treatment of gastric hypersecretory states and peptic ulcers.
Introduction of proton pump inhibitors offered another therapeutic option. Though H-receptor antagonists and proton pump inhibitors 2 are important and useful drugs, the discovery of the link between H. pylori infection and peptic ulcer disease has led to even more effective pharmacotherapeutic regimens.
Our intent in Drug Development: Molecular Targets for GI Diseases is to bring together hands-on experts to review promising areas of gastrointestinal pharmacology. The contemporary topics covered, from a mechanistic viewpoint, are relevant to gastrointestinal inflammation and motility disorders.
Authoritative opinions are offered on both future research directions and potential applications for new therapies.
Format | Inbunden |
Omfång | 278 sidor |
Språk | Engelska |
Förlag | Humana Press Inc. |
Utgivningsdatum | 1999-09-01 |
ISBN | 9780896035898 |
Specifikation
Böcker
- Inbunden, 278, Engelska, Humana Press Inc., 1999-09-01, 9780896035898
Leverans
Vi erbjuder flera smidiga leveransalternativ beroende på ditt postnummer, såsom Budbee Box, Early Bird, Instabox och DB Schenker. Vid köp över 299 kr är leveransen kostnadsfri, annars tillkommer en fraktavgift från 29 kr. Välj det alternativ som passar dig bäst för en bekväm leverans.
Betalning
Du kan betala tryggt och enkelt via Avarda med flera alternativ: Swish för snabb betalning, kortbetalning med VISA eller MasterCard, faktura med 30 dagars betalningstid, eller konto för flexibel delbetalning.
Specifikation
Böcker
- Format Inbunden
- Antal sidor 278
- Språk Engelska
- Förlag Humana Press Inc.
- Utgivningsdatum 1999-09-01
- ISBN 9780896035898